EarningsQ2 2026 Earnings Report

Ondine Biomedical, Inc. (VF5) Q2 2026 Earnings Report

2 Followers

DE:VF5 Q2 2026 EPS Results

Actual EPS-€0.02

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.02

Actual Revenue€786.30K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+21.16%

QuarterQ2 2026

Date09/30/2026

TimeBefore Open

Conference CallWednesday, September 30, 2026

DE:VF5 Upcoming Earnings

Ondine Biomedical, Inc.'s next earnings date is estimated for May 20, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
May 20, 2027	2026 (Q4)	- / -	-0.022	―
Sep 30, 2026	2026 (Q2)	- / -0.02	-0.019	0.00% (0.00)
Jun 04, 2026	2025 (Q4)	- / -0.02	-0.025	9.52% (<+0.01)
Sep 26, 2025	2025 (Q2)	- / -0.02	-0.022	15.79% (<+0.01)
May 15, 2025	2024 (Q4)	- / -0.02	-0.022	-10.53% (>-0.01)
Sep 30, 2024	2024 (Q2)	- / -0.02	-0.028	20.83% (<+0.01)
Jun 07, 2024	2023 (Q4)	- / -0.02	-0.042	47.22% (+0.02)
Sep 25, 2023	2023 (Q2)	- / -0.03	-0.047	40.00% (+0.02)
May 10, 2023	2022 (Q4)	- / -0.04	-0.159	73.53% (+0.12)
Sep 27, 2022	2022 (Q2)	- / -0.02	-0.009	-185.71% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed